title: The year in cardiothoracic and vascular anesthesia: selected highlights from 2009.
abstract: The hybrid operating room is the venue for transcatheter therapy with the convergence of 3 specialties: cardiac surgery, cardiovascular anesthesiology, and interventional cardiology. Transcatheter aortic valve replacement is proof that cardiac specialists have embraced the endovascular revolution. Because pharmacologic conditioning and ischemic myocardial conditioning are safe and effective, they are currently the focus of multiple trials. Angiotensin blockade, anemia, and endoscopic saphenous vein harvesting worsen outcome after coronary artery bypass graft (CABG) surgery. Although off-pump CABG surgery is equivalent to on-pump CABG surgery, it may improve outcomes in high-risk groups. Although percutaneous coronary intervention (PCI) significantly decreases mortality after myocardial infarction, the evidence is less convincing for intra-aortic balloon counterpulsation. Even though prasugrel recently was approved for platelet blockade in PCI, it may be superseded by ticagrelor. Although PCI and CABG surgery appear equivalent for multivessel coronary disease, CABG surgery lowers revascularization rates and also has superior outcomes in diabetics and the elderly. Hetastarch and N-acetylcysteine both increase bleeding and transfusion in cardiac surgery. Factor VII can treat life-threatening bleeding, but its safety requires further evaluation. Because eltrombopag and romiplostim stimulate platelet production, they may have a future role in hemostasis after cardiac surgery. Even though fenoldopam, atrial natriuretic peptide, and sodium bicarbonate are nephroprotective, further trials must confirm these findings. Intensive insulin therapy offers no further outcome advantage and significantly increases hypoglycemic risk. The past year has witnessed the advent of a new clinical venue, new devices, and new drugs. The coming year will most likely advance these achievements.
authors.affiliation: Mayo Clinic, Scottsdale, AZ, USA.
authors.forename: Harish
authors.initials: H
authors.lastname: Ramakrishna
authors.forename: Jens
authors.initials: J
authors.lastname: Fassl
authors.forename: Ashish
authors.initials: A
authors.lastname: Sinha
authors.forename: Prakash
authors.initials: P
authors.lastname: Patel
authors.forename: Hynek
authors.initials: H
authors.lastname: Riha
authors.forename: Michael
authors.initials: M
authors.lastname: Andritsos
authors.forename: Insung
authors.initials: I
authors.lastname: Chung
authors.forename: John G T
authors.initials: JG
authors.lastname: Augoustides
mesh_terms: D000776:Anesthesiology; D018685:Anesthetics, Inhalation; D002404:Catheterization / Q000639:trends; D003324:Coronary Artery Disease / Q000628:therapy; D006331:Heart Diseases / Q000628:therapy; D006488:Hemostasis, Surgical / Q000379:methods; D006801:Humans; D019157:Ischemic Preconditioning, Myocardial / Q000379:methods; D009873:Operating Rooms / Q000458:organization & administration; D013903:Thoracic Surgery / Q000379:methods
chemical_list: D018685:Anesthetics, Inhalation